Anthony Vendetti
Stock Analyst at Maxim Group
(3.66)
# 809
Out of 4,984 analysts
83
Total ratings
31.94%
Success rate
14.52%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $3 | $0.89 | +236.66% | 1 | Sep 9, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $225 → $205 | $88.08 | +132.74% | 6 | Aug 26, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $30 → $10 | $5.91 | +69.35% | 5 | Aug 21, 2025 | |
| CELH Celsius Holdings | Maintains: Buy | $50 → $65 | $55.27 | +17.60% | 8 | Aug 8, 2025 | |
| NEPH Nephros | Maintains: Buy | $4.5 → $6 | $4.31 | +39.21% | 1 | Aug 8, 2025 | |
| LSF Laird Superfood | Initiates: Buy | $12 | $5.63 | +113.14% | 1 | Jun 30, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $3.15 | +217.46% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.49 | +235.57% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.14 | +338.60% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.26 | - | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $0.84 | +495.24% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.40 | +328.57% | 1 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $8.72 | +37.61% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.67 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $1.23 | +550.41% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.33 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $1.27 | +4,624.41% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.94 | +0.60% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.68 | +197.62% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.72 | +3,247.28% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.00 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $0.82 | +143.16% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.89 | +14,024.29% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.60 | +1,068.42% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $23.69 | +5.53% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.33 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $1.79 | +195,430.73% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.89 | +73.01% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.76 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.02 | +194.12% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.64 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $2.88 | +4,166,566.67% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $38.54 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.84 | +86,014.10% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.52 | -52.47% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.54 | - | 1 | May 31, 2016 |
NeuroOne Medical Technologies
Sep 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.89
Upside: +236.66%
Nutex Health
Aug 26, 2025
Maintains: Buy
Price Target: $225 → $205
Current: $88.08
Upside: +132.74%
Dermata Therapeutics
Aug 21, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $5.91
Upside: +69.35%
Celsius Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $55.27
Upside: +17.60%
Nephros
Aug 8, 2025
Maintains: Buy
Price Target: $4.5 → $6
Current: $4.31
Upside: +39.21%
Laird Superfood
Jun 30, 2025
Initiates: Buy
Price Target: $12
Current: $5.63
Upside: +113.14%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $3.15
Upside: +217.46%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.49
Upside: +235.57%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.26
Upside: -
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.84
Upside: +495.24%
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $1.40
Upside: +328.57%
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $8.72
Upside: +37.61%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.67
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.23
Upside: +550.41%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $22.33
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $1.27
Upside: +4,624.41%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $9.94
Upside: +0.60%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.68
Upside: +197.62%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.72
Upside: +3,247.28%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.00
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $0.82
Upside: +143.16%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.89
Upside: +14,024.29%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.60
Upside: +1,068.42%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $23.69
Upside: +5.53%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.33
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $1.79
Upside: +195,430.73%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.89
Upside: +73.01%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.76
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.02
Upside: +194.12%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $16.64
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $2.88
Upside: +4,166,566.67%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $38.54
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.84
Upside: +86,014.10%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.52
Upside: -52.47%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $16.54
Upside: -